enteroaggregative e. coli

Cell therapyexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2008 (NCT00362869)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • enteroaggregative e. coli

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00362869Phase 1Feb 1, 2008National Institute of Allergy and Infectious Diseases (NIAID)
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Institute of Allergy and Infectious Diseases (NIAID)Government1112008
1 organizations
Page 1 / 1